The purpose of this feasibility study is to determine whether it is practical and helpful to provide problem-solving therapy to stroke survivors and their spouses/partners (caregivers) together. It will also compare the experiences of participants who receive problem-solving therapy to those who receive stroke-related health education. Many stroke survivors and caregivers report feeling sad or blue at some point after the stroke. These feelings can impact quality of life. Encountering problems is a part of daily life. These problems can be big or small, but sometimes they can pile up and feel overwhelming, contributing to feelings of sadness. Problem-solving therapy is a tool that teaches structured ways to address current problems or challenges in your life. Participants who are assigned to receive problem-solving therapy will work with a research team member for six, one-hour sessions. During each session, participants will identify a problem (big or small) and create a plan to work on that problem. Participants who are assigned to receive stroke-related health education will work with a research team member who will teach them about various topics related to stroke over six, one-hour sessions. Each session will cover information about a different topic related to stroke. Outcomes data will be collected at approximately 4 weeks, 8 weeks, and 13 weeks from baseline.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
28
Problem-Solving Therapy is a brief psychosocial intervention for management of depressive symptoms. Participants will have six, one-hour sessions with an interventionist to learn a structured approach to problem-solving.
The stroke-related health education program will teach participants about various topics related to stroke. Participants will have six, one-hour sessions with an interventionist to learn about different topics related to stroke.
Allina Health
Minneapolis, Minnesota, United States
Study Retention
Total percentage of participants who complete the study.
Time frame: Through study completion, an average of 13 weeks.
Protocol Adherence
Total percentage of protocol-specified activities completed by enrolled participants.
Time frame: Through study completion, an average of 13 weeks.
Intervention Acceptability
Participant experience collected via self-report survey.
Time frame: Post-intervention, at approximately 8 weeks.
Study Recruitment Success
Percentage of eligible candidates who enroll in the study.
Time frame: At initial contact.
Pre/post-intervention changes in depressive symptoms among caregivers.
Pre/post-intervention changes in 9-item Patient Health Questionnaire (PHQ-9) scores.
Time frame: Baseline and post-intervention, covering an average of 8 weeks.
Pre/post-intervention changes in quality of life among caregivers.
Pre/post-intervention changes in Euroqol 5-item QOL scale (EQ-5D) scores.
Time frame: Baseline and post-intervention, covering an average of 8 weeks.
Pre/post-intervention changes in depressive symptoms among stoke survivors.
Pre/post-intervention changes in 9-item Patient Health Questionnaire (PHQ-9) scores.
Time frame: Baseline and post-intervention, covering an average of 8 weeks.
Pre/post-intervention changes in quality of life among stoke survivors.
Pre/post-intervention changes in Euroqol 5-item QOL scale (EQ-5D) scores.
Time frame: Baseline and post-intervention, covering an average of 8 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.